Current News Strand Therapeutics is awarded NIH SBIR contract to develop mRNA-based CAR-T immunotherapy for non-Hodgkin’s lymphoma Posted on November 9, 2021November 9, 2021 by Nour Obeidallah 09 Nov Nour Obeidallah Kintsugi named in “5 Startups Shaping the Future of Health Care” list by Inc. PhagoMed Biopharma GmbH acquired by BioNTech. The acquisition will accelerate the development of their synthetic lysin platform
